Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma

Histopathology

Volumn 61, Issue 5, 2012, Pages 899-909

  Requena, Celia ^a   Rubio, Luis ^a   Traves, Victor ^a   Sanmartín, Onofre ^a   Nagore, Eduardo ^a   Llombart, Beatriz ^a   Serra, Carlos ^a   Fernández Serra, Antonio ^a   Botella, Rafael ^a   Guillén, Carlos ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

Fluorescence in situ hybridization; Spitz naevus; Spitzoid melanoma

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CCND1 GENE; CENTROMERE 6 GENE; CHILD; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; GENE; GENE DOSAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JUVENILE MELANOMA; MALE; MELANOMA; MYB GENE; PRIORITY JOURNAL; RREB1 GENE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SPITZOID MELANOMA;

ADULT; CHILD; CHROMOSOME ABERRATIONS; CYCLIN D1; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FEMALE; GENE DOSAGE; GENES, MYB; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MELANOMA; MIDDLE AGED; NEVUS, EPITHELIOID AND SPINDLE CELL; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84868099343     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04293.x     Document Type: Article

References (51)

1. Mones JM, Ackerman AB. 'Atypical' Spitz's nevus, 'malignant' Spitz's nevus, and 'metastasizing' Spitz's nevus: a critique in historical perspective of three concepts flawed fatally. Am. J. Dermatopathol. 2004; 26; 310-333.
2. Barnhill RL. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, 'Spitzoid melanoma' and risk assessment. Mod. Pathol. 2006; 19(Suppl 2); S21-S33.
3. Cerroni L. Spitzoid tumors: a matter of perspective? Am. J. Dermatopathol. 2004; 26; 1-3.
4. Barnhill RL, Argenyi ZB, From L et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum. Pathol. 1999; 30; 513-520.
5. Weedon D, Little JH. Spindle and epithelioid cell nevi in children and adults. A review of 211 cases of the Spitz nevus. Cancer 1977; 40; 217-225.
6. Paniago-Pereira C, Maize JC, Ackerman AB. Nevus of large spindle and/or epithelioid cells (Spitz's nevus). Arch. Dermatol. 1978; 114; 1811-1823.
7. Kamino H, Flotte TJ, Misheloff E et al. Eosinophilic globules in Spitz's nevi, new findings and a diagnostic sign. Am. J. Dermatopathol. 1979; 1; 319-324.
8. Crotty KA. Spitz naevus: histological features and distinction from malignant melanoma. Australas. J. Dermatol. 1997; 38(Suppl 1); S49-S53.
9. Hantschke M, Bastian BC, LeBoit PE. Consumption of the epidermis: a diagnostic criterion for the differential diagnosis of melanoma and Spitz nevus. Am. J. Surg. Pathol. 2004; 28; 1621-1625.
10. Cesinaro AM, Foroni M, Sighinolfi P et al. Spitz nevus is relatively frequent in adults: a clinico-pathologic study of 247 cases related to patient's age. Am. J. Dermatopathol. 2005; 27; 469-475.
11. Massi G, LeBoit P. Histological diagnosis of nevi and melanoma. Germany: Steinkopff Verlag Darmstadt, 2004.
12. Mooi WJ. Histopathology of Spitz naevi and 'Spitzoid' melanomas. Curr. Top. Pathol. 2001; 94; 65-77.
13. Walsh N, Crotty K, Palmer A et al. Spitz nevus versus spitzoid malignant melanoma: an evaluation of the current distinguishing histopathologic criteria. Hum. Pathol. 1998; 29; 1105-1112.
14. Crotty KA, Scolyer RA, Li L et al. Spitz naevus versus Spitzoid melanoma: when and how can they be distinguished? Pathology 2002; 34; 6-12.
15. Mooi WJ. Spitz nevus and its histologic simulators. Adv. Anat. Pathol. 2002; 9; 209-221.
16. Barnhill RL. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, 'Spitzoid melanoma' and risk assessment. Mod. Pathol. 2006; 19; S21-S33.
17. Binder SW, Asnong C, Paul E et al. The histology and differential diagnosis of Spitz nevus. Semin. Diagn. Pathol. 1993; 10; 36-46.
18. Requena C, Requena L, Kutzner H et al. Spitz nevus: a clinicopathological study of 349 cases. Am. J. Dermatopathol. 2009; 31; 107-116.
19. Requena C, Requena L. Diagnostic clues for spitzoid melanoma. Piel 2009; 24; 542-548.
20. Requena C, Botella R, Nagore E et al. Characteristics of spitzoid melanoma and clues for differential diagnosis with Spitz nevus. Am. J. Dermatopathol. 2012; [Epub ahead of print] doi: 10.1097/DAD.0b013e318234e780.
21. Ribe A, McNutt NS. S100A6 protein expression is different in Spitz nevi and melanomas. Mod. Pathol. 2003; 16; 505-511.
22. Bergman R, Dromi R, Trau H et al. The pattern of HMB-45 antibody staining in compound Spitz nevi. Am. J. Dermatopathol. 1995; 17; 542-546.
23. Kapur P, Selim MA, Roy LC et al. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. Mod. Pathol. 2005; 18; 197-204.
24. Simonetti O, Lucarini G, Brancorsini D et al. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. Cancer 2002; 95; 1963-1970.
25. Nagasaka T, Lai R, Medeiros LJ et al. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study. Am. J. Dermatopathol. 1999; 21; 115-120.
26. Bergman R, Shemer A, Levy R et al. Immunohistochemical study of p53 protein expression in Spitz nevus as compared with other melanocytic lesions. Am. J. Dermatopathol. 1995; 17; 547-550.
27. Kaleem Z, Lind AC, Humphrey PA et al. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas? Mod. Pathol. 2000; 13; 217-222.
28. Kanter-Lewensohn L, Hedblad MA, Wejde J et al. Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas. Mod. Pathol. 1997; 10; 917-920.
29. Li LX, Crotty KA, McCarthy SW et al. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Am. J. Dermatopathol. 2000; 22; 489-495.
30. Fullen DR, Zhu W, Thomas D et al. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue. J. Cutan. Pathol. 2005; 32; 680-684.
31. Isabel Zhu Y, Fitzpatrick JE. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma. J. Cutan. Pathol. 2006; 33; 33-37.
32. Bergman R, Azzam H, Sprecher E et al. A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas. J. Am. Acad. Dermatol. 2000; 42; 496-500.
33. Penneys N, Seigfried E, Nahass G et al. Expression of proliferating cell nuclear antigen in Spitz nevus. J. Am. Acad. Dermatol. 1995; 32; 964-967.
34. Garrido-Ruiz MC, Requena L, Ortiz P et al. The immunohistochemical profile of Spitz nevi and convencional (non-spitzoid) melanomas: a baseline study. Mod. Pathol. 2010; 23; 1215-1224.
35. Gerami P, Jewell SS, Morrison LE et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am. J. Surg. Pathol. 2009; 33; 1146-1156.
36. Pouryazdanparast P, Newman M, Mafee M et al. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization. Am. J. Surg. Pathol. 2009; 33; 1396-1400.
37. Newman MD, Lertsburapa T, Mirzabeigi M et al. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma. Mod. Pathol. 2009; 22; 989-995.
38. Morey AL, Murali R, McCarthy SW et al. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology 2009; 41; 383-387.
39. Gerami P, Mafee M, Lurtsbarapa T et al. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes. Arch. Dermatol. 2010; 146; 273-278.
40. Dalton SR, Gerami P, Kolaitis NA et al. Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma. Am. J. Surg. Pathol. 2010; 34; 231-237.
41. Balaban G, Herlyn M, Guerry D et al. Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet. Cytogenet. 1984; 11; 429-439.
42. Bastian BC, Leboit PE, Hamm H et al. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res. 1998; 58; 2170-2175.
43. Bastian BC, Olshen AB, Leboit PE et al. Classifying melanocytic tumors based on DNA copy number changes. Am. J. Pathol. 2003; 163; 1765-1770.
44. Cowan JM, Halaban R, Francke U. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J. Natl Cancer Inst. 1988; 80; 1159-1164.
45. Limon J, Dal CP, Sait SN et al. Chromosome changes in metastático human melanoma. Cancer Genet. Cytogenet. 1988; 30; 201-211.
46. Parmiter AH, Nowell PC. The cytogenetics of human malignant melanoma and premalignant lesions. Cancer Treat. Res. 1988; 43; 47-61.
47. Bastian BC, Wesselmann U, Pinkel D et al. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J. Invest. Dermatol. 1999; 113; 1065-1069.
48. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am. J. Pathol. 2000; 157; 967-972.
49. Gaiser T, Kutzner H, Palmedo G et al. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up. Mod. Pathol. 2010; 23; 413-419.
50. Isaac AK, Lertsburapa T, Pathria Mundi J et al. Polyploidy in Spitz nevi: a not uncommon karyotypic abnormality identifiable by fluorescence in situ hybridization. Am. J. Dermatopathol. 2010; 32; 114-118.
51. Sangueza OP, Hyder DM, White CR Jr et al. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin. Anal. Quant. Cytol. Histol. 1992; 14; 55-59.